TS

Torben Straight Nissen

Executive Partner at Flagship Pioneering, Chairman and CEO of Repertoire Immune Medicines, Chairman of Etiome

Boston, Massachusetts

Investor
VC

Invests in

Stages:

Series A
Seed

  • Min Investment:

    $500,000.00

  • Max Investment:

    $15,000,000.00

  • Target Investment:

    $7,000,000.00

Skills

Project Management
Management
Biotechnology
Pharmaceutical Industry
Lifesciences
Protein Chemistry
Drug Development
Clinical Development
Drug Discovery
Biopharmaceuticals
Leadership

Education

Lists including Torben Straight

AM
AR
AB
AF

Based in Boston & Cambridge

668 people

AT
AS
AT
AH

All Series A Investors

14748 people

AM
AT
AS
AR

All Seed Investors

19691 people

SF
SS
ST
SJ

Pre-Seed Investors in Boston

71 people

Work Experience

FP
Flagship Pioneering

2016

  • Executive Partner

    2022

  • Senior Partner

    2019 - 2023

  • Venture Partner

    2016 - 2019

E
Etiome

2025

  • Chairman

    2025

RI
Repertoire Immune Medicines

2022

  • Chairman and Chief Executive Officer

    2024

  • Chief Executive Officer

    2022 - 2024

FL84

2021 - 2025

  • Founding CEO

    2021 - 2025

RT
Ring Therapeutics

2018 - 2021

  • Board Member

    2018 - 2021

RT
Rubius Therapeutics

2016 - 2019

  • President

    2016 - 2019

P
Pfizer

2011 - 2016

  • Vice President, Strategic Portfolio Management and Planning, Worldwide R&D

    2015 - 2016

  • Head, Strategy, Portfolio and Operations, BioTherapeutics R&D

    2014 - 2015

  • Chief Operating Officer, Centers for Therapeutic Innovation

    2012 - 2014

  • Managing Director & Head of Project and Portfolio Management, Centers for Therapeutic Innovation

    2011 - 2012

Ascendis Pharma

2008 - 2011

  • Chief Operations Officer

    2008 - 2011

m
moksha8

2007 - 2008

  • President, Biologics and Senior Vice President, moksha8

    2007 - 2008

M
Maxygen

2000 - 2007

  • Managing Director

    2005 - 2007

  • Senior Vice President, Global Project Management

    2005 - 2006

  • Vice President, Global Project Management

    2004 - 2005

  • Director, Protein Pharmaceuticals

    2002 - 2004

  • Principle Scientist and Project Leader

    2000 - 2002